EPISODE · Nov 5, 2025 · 6 MIN
Novo Nordisk CEO Mike Doustdar Talks Drug Sales
from Bloomberg Talks · host Bloomberg
Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mike Doustdar. He spoke to Bloomberg's Guy Johnson about the experience so far. See omnystudio.com/listener for privacy information.
NOW PLAYING
Novo Nordisk CEO Mike Doustdar Talks Drug Sales
No transcript for this episode yet
Similar Episodes
Feb 8, 2026 ·26m
Jan 29, 2026 ·39m
Jan 14, 2026 ·25m
Jan 8, 2026 ·7m
Jan 7, 2026 ·45m